Beth Israel suffers large data breach

laptoplock - 213.47 Kb
Beth Israel Deaconess Medical Center (BIDMC) in Boston is in the process of notifying approximately 3,900 patients of a potential breach of protected health information (PHI) as a result of a physician's stolen personal laptop computer.

The computer was stolen from the office of a BIDMC physician on May 22. The computer, which contained a tracking device, has not been recovered nor has the tracking device been activated.

In addition to notifying law enforcement, which arrested a suspect in the theft, BIDMC engaged a national forensic firm to investigate whether data were compromised.

There has been no indication that any information has been misused. The laptop contained files that included short summaries of medical information used for administrative purposes within BIDMC, but did not contain complete medical records and did not contain patient financial information such as Social Security numbers. The stolen laptop also contained approximately 230 administrative employee records.

“We take the incident extremely seriously, and have now accelerated implementation of a program to assist employees with protecting devices they purchase personally,” said John Halamka, MD, BIDMC’s CIO. “We deeply regret and apologize for any concern or inconvenience this situation may cause our patients and families.”

BIDMC has enhanced physical security in office buildings and mounted a campaign to raise awareness about data security issues within the organization at all levels. The facility also announced plans to notify affected patients through the U.S. Postal Service and provide them with a toll-free telephone number.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.